Low hepatitis B surface antigen at baseline and increased ALT levels during treatment predicts significant HBsAg decline in peginterferon alfa added to long-term nucleus(t)ice analogue. Results from two randomized controlled trials in 165 patients

Subjects

Subjects :

Hepatology

Details

ISSN :

01688278

Volume :

73

Database :

OpenAIRE

Journal :

Journal of Hepatology

Accession number :

edsair.doi...........7763446d3393e0bea529490cef810668